Joy Zhang
Stock Analyst at SVB Leerink
(0.41)
# 3,116
Out of 4,433 analysts
10
Total ratings
25%
Success rate
-21.03%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Upgrades: Market Perform | n/a | $14.04 | - | 3 | Nov 8, 2022 | |
| OMCL Omnicell | Maintains: Market Perform | $117 → $54 | $31.66 | +70.56% | 2 | Nov 3, 2022 | |
| CERT Certara | Maintains: Outperform | $29 → $26 | $16.47 | +57.86% | 2 | Aug 10, 2022 | |
| OPRX OptimizeRx | Maintains: Outperform | $38 → $30 | $12.85 | +133.46% | 2 | Aug 10, 2022 | |
| IQV IQVIA Holdings | Initiates: Outperform | $256 | $235.00 | +8.94% | 1 | Jul 15, 2022 |
Hims & Hers Health
Nov 8, 2022
Upgrades: Market Perform
Price Target: n/a
Current: $14.04
Upside: -
Omnicell
Nov 3, 2022
Maintains: Market Perform
Price Target: $117 → $54
Current: $31.66
Upside: +70.56%
Certara
Aug 10, 2022
Maintains: Outperform
Price Target: $29 → $26
Current: $16.47
Upside: +57.86%
OptimizeRx
Aug 10, 2022
Maintains: Outperform
Price Target: $38 → $30
Current: $12.85
Upside: +133.46%
IQVIA Holdings
Jul 15, 2022
Initiates: Outperform
Price Target: $256
Current: $235.00
Upside: +8.94%